Fresenius Medical Care Sees US Plans for Kidney Disease as Positive
Thousands of end stage renal disease experts turn to Renal Therapies Group for pharmaceuticals and the most prescribed technologies in the industry.
Power your practice with our resources. We're here to help support your patients and your thriving practice.
Every day, we’re working tirelessly to transform the future of healthcare. Because every patient deserves treatment as strong as they are.
Browser Upgrade Recommended: Our website has detected that you are using a version of Internet Explorer that will prevent you from accessing certain features on FMCNA.com. We strongly recommend that you use a different browser to optimize your viewing experience. Supported browsers include Chrome, Edge, Firefox, and Safari.
Donnie King, a renal patient who attends dialysis three times a week at Fresenius Kidney Care in Mississippi, discusses the benefits he receives from participating in clinical trials with Frenova Renal Research. Donnie says his experience has been rewarding and that “it’s a great way to give back and make a difference.”
Frenova Renal Research, a division of Fresenius Medical Care North America, is a contract clinical research services business with a world-class network of more than 450 principal investigators across 260 research sites. The company operates at the intersection of clinical research and clinical care, helping patients like Donnie participate in our mission to advance the science of renal therapies.
Insight: Advancing Medicine by Routinely Offering Clinical Research to Patients by Kurt Mussina
Website: Frenova Renal Research